Sammy Karam - 23 Dec 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
23 Dec 2021
Net transactions value
-$658,023
Form type
4
Filing time
28 Dec 2021, 16:39:40 UTC
Previous filing
19 Aug 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale $658,023 -4,700 -21% $140.00 18,226 23 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140 to $140.01, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).